Revolution Medicines
Executive Director, Global Commercial Precision Medicine & Companion Diagnostics
Remote (United States) · Director · Full-time
Sponsorship not specified$252k-$315kDetected 22 hours ago
Data AnalysisComplianceBusiness DevelopmentLeadershipCommunicationCollaboration
About the role
- Candidates should be passionate about leading cross-functional collaboration, building new commercial capabilities, and contributing as both a strategic leader and hands-on driver in a growing organization.
- This position will partner closely with internal stakeholders and external diagnostic partners to ensure global readiness for precision oncology commercialization.
- Reporting to the SVP, Global Commercial Development, this leadership role will serve as the Global Commercial Lead for Precision Medicine & Companion Diagnostics, responsible for defining, developing, and executing the global commercial precision medicine strategy across the Revolution Medicines portfolio.
Responsibilities
- Partner with Market Access to develop HTA and evidence strategies that optimize diagnostic access and patient access.
- Ensure global readiness to support successful companion diagnostic development, launch planning, commercialization, and lifecycle management across the U.S. and key ex-U.S. markets.
- Develop and refine global precision medicine plans, including testing forecasts, market readiness assessments, investment priorities, and lifecycle strategies to support portfolio decision-making.
- Provide commercial precision medicine leadership to portfolio strategy, development milestones, and investment decisions, ensuring companion diagnostic and testing strategies are incorporated early to support long-term commercial success.
- Drive excellence in global diagnostic launch execution by creating launch frameworks, sharing best practices across affiliates, and monitoring readiness to proactively resolve challenges including Define and track KPIs for testing adoption, diagnostic access, launch readiness, and commercial performance.
- Establish and lead strategic partnerships with diagnostic companies, laboratory networks, technology providers, and other external stakeholders to expand testing access, enable scalable diagnostic solutions, and support successful global companion diagnostic commercialization.
- Build relationships with advocacy groups, professional societies, payers, and diagnostic organizations to advance testing adoption.
- Serve as a trusted resource to executive leadership in identifying opportunities to optimize patient identification, expand testing access, strengthen competitive differentiation, and maximize commercial value across the portfolio.
- Drive innovation in global precision medicine by collaborating with Commercial IS and cross-functional teams to leverage digital capabilities, data analytics, and omnichannel approaches that enhance biomarker testing, patient identification, and customer adoption.
- Define long term RevMed needs and build out appropriate resources and teams
Requirements
- Minimum of 15+ years of progressive biotechnology or pharmaceutical industry experience, including significant leadership in precision medicine, companion diagnostics, oncology commercialization, or related functions.
- Up to 50% travel required.
Nice to have
- Preferred Skills:
Skills
- Bachelor's degree required.
- Experience leading precision medicine strategy for oncology launches.
- Enterprise-level strategic thinking with the ability to balance scientific, regulatory, commercial, and patient access considerations.
- Entrepreneurial mindset with comfort operating in ambiguity and a passion for improving outcomes for cancer patients.
- Advanced scientific degree (MS, PhD, PharmD) and/or MBA.
- Experience with biomarker-defined solid tumors and targeted therapies.
- Prior experience in a rapidly growing biotechnology company.
- Experience building global laboratory networks and diagnostic partnerships.
- #LI-JW1 #LI-Remote
- The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below.
- For additional information, please contact privacy@revmed.com.
- Base Pay Salary Range
Compensation
- $252,000 - $315,000 USD
- Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process.
Benefits
- Lead market development initiatives to drive biomarker education, stakeholder engagement, and appropriate reporting of RAS and other actionable mutations.
- Required Skills, Experience and Education:
- Strong understanding of global companion diagnostic development, regulatory pathways, laboratory medicine, reimbursement, and testing ecosystems.
- Experience leading cross-functional initiatives and influencing senior stakeholders across Commercial, Medical Affairs, Clinical Development, Market Access, Regulatory, and Business Development.
Company info
- Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
- The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.
- The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
- As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
Apply directly at Revolution Medicines →Create a free account for alerts like thisView Revolution Medicines immigration profile
This listing is sourced directly from Revolution Medicines's careers page and normalized into a canonical job model.